- Home
- CELZ vs ACON Comparison
CELZ vs ACON Comparison
Compare CELZ & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- ACON
- Stock Information
- Founded
- CELZ 1998
- ACON 2008
- Country
- CELZ United States
- ACON United States
- Employees
- CELZ N/A
- ACON N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- CELZ Health Care
- ACON Technology
- Exchange
- CELZ Nasdaq
- ACON Nasdaq
- Market Cap
- CELZ 5.5M
- ACON 4.8M
- IPO Year
- CELZ N/A
- ACON 2022
- Fundamental
- Price
- CELZ $2.18
- ACON $6.48
- Analyst Decision
- CELZ
- ACON Buy
- Analyst Count
- CELZ 0
- ACON 2
- Target Price
- CELZ N/A
- ACON $481.00
- AVG Volume (30 Days)
- CELZ 30.8K
- ACON 18.4K
- Earning Date
- CELZ 05-09-2025
- ACON 05-15-2025
- Dividend Yield
- CELZ N/A
- ACON N/A
- EPS Growth
- CELZ N/A
- ACON N/A
- EPS
- CELZ N/A
- ACON N/A
- Revenue
- CELZ $14,000.00
- ACON $54,601.00
- Revenue This Year
- CELZ N/A
- ACON $212.31
- Revenue Next Year
- CELZ N/A
- ACON N/A
- P/E Ratio
- CELZ N/A
- ACON N/A
- Revenue Growth
- CELZ 55.56
- ACON N/A
- 52 Week Low
- CELZ $1.69
- ACON $6.20
- 52 Week High
- CELZ $6.90
- ACON $3,499.51
- Technical
- Relative Strength Index (RSI)
- CELZ 55.59
- ACON 34.00
- Support Level
- CELZ $1.93
- ACON $6.50
- Resistance Level
- CELZ $2.02
- ACON $7.18
- Average True Range (ATR)
- CELZ 0.10
- ACON 0.37
- MACD
- CELZ 0.03
- ACON 1.22
- Stochastic Oscillator
- CELZ 86.21
- ACON 14.50
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.